Literature DB >> 26655497

Improving drug discovery with high-content phenotypic screens by systematic selection of reporter cell lines.

Jungseog Kang1,2, Chien-Hsiang Hsu1,3,4, Qi Wu1, Shanshan Liu1, Adam D Coster1, Bruce A Posner5, Steven J Altschuler1,4, Lani F Wu1,4.   

Abstract

High-content, image-based screens enable the identification of compounds that induce cellular responses similar to those of known drugs but through different chemical structures or targets. A central challenge in designing phenotypic screens is choosing suitable imaging biomarkers. Here we present a method for systematically identifying optimal reporter cell lines for annotating compound libraries (ORACLs), whose phenotypic profiles most accurately classify a training set of known drugs. We generate a library of fluorescently tagged reporter cell lines, and let analytical criteria determine which among them--the ORACL--best classifies compounds into multiple, diverse drug classes. We demonstrate that an ORACL can functionally annotate large compound libraries across diverse drug classes in a single-pass screen and confirm high prediction accuracy by means of orthogonal, secondary validation assays. Our approach will increase the efficiency, scale and accuracy of phenotypic screens by maximizing their discriminatory power.

Entities:  

Mesh:

Year:  2015        PMID: 26655497      PMCID: PMC4844861          DOI: 10.1038/nbt.3419

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  53 in total

Review 1.  Functional proteomics to dissect tyrosine kinase signalling pathways in cancer.

Authors:  Walter Kolch; Andrew Pitt
Journal:  Nat Rev Cancer       Date:  2010-08-19       Impact factor: 60.716

2.  Dynamic proteomics in individual human cells uncovers widespread cell-cycle dependence of nuclear proteins.

Authors:  Alex Sigal; Ron Milo; Ariel Cohen; Naama Geva-Zatorsky; Yael Klein; Inbal Alaluf; Naamah Swerdlin; Natalie Perzov; Tamar Danon; Yuvalal Liron; Tal Raveh; Anne E Carpenter; Galit Lahav; Uri Alon
Journal:  Nat Methods       Date:  2006-07       Impact factor: 28.547

3.  A shrinkage approach to large-scale covariance matrix estimation and implications for functional genomics.

Authors:  Juliane Schäfer; Korbinian Strimmer
Journal:  Stat Appl Genet Mol Biol       Date:  2005-11-14

4.  Identifying off-target effects and hidden phenotypes of drugs in human cells.

Authors:  Marnie L MacDonald; Jane Lamerdin; Stephen Owens; Brigitte H Keon; Graham K Bilter; Zhidi Shang; Zhengping Huang; Helen Yu; Jennifer Dias; Tomoe Minami; Stephen W Michnick; John K Westwick
Journal:  Nat Chem Biol       Date:  2006-05-07       Impact factor: 15.040

5.  Dynamic proteomics of individual cancer cells in response to a drug.

Authors:  A A Cohen; N Geva-Zatorsky; E Eden; M Frenkel-Morgenstern; I Issaeva; A Sigal; R Milo; C Cohen-Saidon; Y Liron; Z Kam; L Cohen; T Danon; N Perzov; U Alon
Journal:  Science       Date:  2008-11-20       Impact factor: 47.728

6.  Using functional signature ontology (FUSION) to identify mechanisms of action for natural products.

Authors:  Malia B Potts; Hyun Seok Kim; Kurt W Fisher; Youcai Hu; Yazmin P Carrasco; Gamze Betul Bulut; Yi-Hung Ou; Mireya L Herrera-Herrera; Federico Cubillos; Saurabh Mendiratta; Guanghua Xiao; Matan Hofree; Trey Ideker; Yang Xie; Lily Jun-shen Huang; Robert E Lewis; John B MacMillan; Michael A White
Journal:  Sci Signal       Date:  2013-10-15       Impact factor: 8.192

7.  Identification of a small molecule that induces mitotic arrest using a simplified high-content screening assay and data analysis method.

Authors:  Christopher J Wilson; Ying Si; Craig M Thompsons; Andrew Smellie; Mark A Ashwell; Ji-Feng Liu; Ping Ye; Daniel Yohannes; Shi-Chung Ng
Journal:  J Biomol Screen       Date:  2005-10-18

8.  Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation.

Authors:  Mayumi Ono; Akira Hirata; Takuro Kometani; Miho Miyagawa; Shu-ichi Ueda; Hisafumi Kinoshita; Teruhiko Fujii; Michihiko Kuwano
Journal:  Mol Cancer Ther       Date:  2004-04       Impact factor: 6.261

9.  Multiplex cytological profiling assay to measure diverse cellular states.

Authors:  Sigrun M Gustafsdottir; Vebjorn Ljosa; Katherine L Sokolnicki; J Anthony Wilson; Deepika Walpita; Melissa M Kemp; Kathleen Petri Seiler; Hyman A Carrel; Todd R Golub; Stuart L Schreiber; Paul A Clemons; Anne E Carpenter; Alykhan F Shamji
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

10.  Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.

Authors:  Baozhi Chen; Michael E Dodge; Wei Tang; Jianming Lu; Zhiqiang Ma; Chih-Wei Fan; Shuguang Wei; Wayne Hao; Jessica Kilgore; Noelle S Williams; Michael G Roth; James F Amatruda; Chuo Chen; Lawrence Lum
Journal:  Nat Chem Biol       Date:  2009-01-04       Impact factor: 15.040

View more
  32 in total

Review 1.  Chemical probes and drug leads from advances in synthetic planning and methodology.

Authors:  Christopher J Gerry; Stuart L Schreiber
Journal:  Nat Rev Drug Discov       Date:  2018-04-13       Impact factor: 84.694

Review 2.  Applications of chemogenomic library screening in drug discovery.

Authors:  Lyn H Jones; Mark E Bunnage
Journal:  Nat Rev Drug Discov       Date:  2017-01-20       Impact factor: 84.694

Review 3.  Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.

Authors:  Maria Letizia Ciavatta; Florence Lefranc; Marianna Carbone; Ernesto Mollo; Margherita Gavagnin; Tania Betancourt; Ramesh Dasari; Alexander Kornienko; Robert Kiss
Journal:  Med Res Rev       Date:  2016-12-07       Impact factor: 12.944

4.  Macrophage Cytological Profiling and Anti-Inflammatory Drug Discovery.

Authors:  Tannia A Lau; Walter M Bray; R Scott Lokey
Journal:  Assay Drug Dev Technol       Date:  2019-01       Impact factor: 1.738

5.  Cytotoxicity Test Based on Human Cells Labeled with Fluorescent Proteins: Fluorimetry, Photography, and Scanning for High-Throughput Assay.

Authors:  Marina A Kalinina; Dmitry A Skvortsov; Maria P Rubtsova; Ekaterina S Komarova; Olga A Dontsova
Journal:  Mol Imaging Biol       Date:  2018-06       Impact factor: 3.488

6.  Patterns of Early p21 Dynamics Determine Proliferation-Senescence Cell Fate after Chemotherapy.

Authors:  Chien-Hsiang Hsu; Steven J Altschuler; Lani F Wu
Journal:  Cell       Date:  2019-06-13       Impact factor: 41.582

7.  High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds.

Authors:  Mattia Zampieri; Balazs Szappanos; Maria Virginia Buchieri; Andrej Trauner; Ilaria Piazza; Paola Picotti; Sébastien Gagneux; Sonia Borrell; Brigitte Gicquel; Joel Lelievre; Balazs Papp; Uwe Sauer
Journal:  Sci Transl Med       Date:  2018-02-21       Impact factor: 17.956

Review 8.  Towards systems tissue engineering: Elucidating the dynamics, spatial coordination, and individual cells driving emergent behaviors.

Authors:  Matthew S Hall; Joseph T Decker; Lonnie D Shea
Journal:  Biomaterials       Date:  2020-06-14       Impact factor: 12.479

Review 9.  The impact of non-genetic heterogeneity on cancer cell death.

Authors:  Zintis Inde; Scott J Dixon
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-12-18       Impact factor: 8.250

10.  Live-cell phenotypic-biomarker microfluidic assay for the risk stratification of cancer patients via machine learning.

Authors:  Michael S Manak; Jonathan S Varsanik; Brad J Hogan; Matt J Whitfield; Wendell R Su; Nikhil Joshi; Nicolai Steinke; Andrew Min; Delaney Berger; Robert J Saphirstein; Gauri Dixit; Thiagarajan Meyyappan; Hui-May Chu; Kevin B Knopf; David M Albala; Grannum R Sant; Ashok C Chander
Journal:  Nat Biomed Eng       Date:  2018-09-17       Impact factor: 25.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.